PedAM
Pediatric Disease Annotations & Medicines
| Disease | hypoglycemia |
| Phenotype | C0020456|hyperglycemia |
| Sentences | 21 |
| PubMedID- 23806096 | This study confirms our previous results that recovering hypoglycemia with hyperglycemia worsens endothelial function and inflammation, being oxidative stress generation the possible cause of this effect [10]. |
| PubMedID- 22701841 | Alcohol is implicated in fasting hyperglycemia, potentiation of drug-induced hypoglycemia or reactive hypoglycemia, hypoglycemia unawareness, synergistic effect on neuropathy and retinopathy, interaction with antidiabetic agents (lactic acidosis with metformin, disulfiram like reaction with chlorpropamide, hepatopathy leading to reduction in dose). |
| PubMedID- 21838054 | In the treatment of type 2 diabetes aimed at prevention of cardiovascular events impacting the prognosis of affected patients, it is critically important not only to lower hbalc values but to find a way to improve postprandial hyperglycemia without causing hypoglycemia thus minimizing drastic glycemic variations or to maintain favorable glycemic control with daily glycemic variations in mind. |
| PubMedID- 21402737 | Conclusion: when over-riding iit cdss recommendations, nurses overwhelmingly administered ltr doses, which emphasized prevention of hypoglycemia but interfered with hyperglycemia control, especially when bg was >150 mg/dl. |
| PubMedID- 22986916 | Results: continuous glucose monitoring before treatment showed asymptomatic hypoglycemia with postprandial hyperglycemia (2.5 g/l, 13.75 mmol/l). |
| PubMedID- 21731863 | As these drugs target hyperglycemia independently of insulin, risk of hypoglycemia should be negligible. |
| PubMedID- 20071562 | However, there is no change in the order of perfusion of different islet endocrine cell types in hypoglycemia compared with hyperglycemia, with the islet core of beta-cells usually perfused first. |
| PubMedID- 21437084 | Metformin monotherapy is a highly appropriate first-line pharmaceutical intervention as it reduces hyperglycemia without concomitant hypoglycemia or weight gain – side effects that are problematic with hypoglycemic agents. |
| PubMedID- 22675341 | Due to this properties, the hormone reduces hyperglycemia without inducing hypoglycemia in patients with type 2 diabetes [3]. |
| PubMedID- 22336443 | One candidate is glycemic variability, which must be differentiated from postprandial hyperglycemia since hypoglycemia can also result in inflammatory activation. |
| PubMedID- 25317246 | Treatment of type 1 diabetes mellitus has always posed a challenge to balance hyperglycemia control with hypoglycemia episodes. |
| PubMedID- 22145468 | Both cases presented typical clinical features of hepatomegaly, hypophosphatemic rickets, severely stunted growth, fasting hypoglycemia along with postprandial hyperglycemia, and proximal renal tubular dysfunction with disproportionately severe glucosuria. |
| PubMedID- 23214078 | Thus, dpp-4 inhibitor can improve postprandial hyperglycemia, without causing hypoglycemia in patients with diabetes. |
| PubMedID- 20929995 | Several factors may explain the observed reduction in cvd events and hospitalization in exenatide versus non–exenatide-treated patients: greater reduction of hyperglycemia with less hypoglycemia and/or improvement in cvd risk factors, including weight, lipids, and blood pressure (14). |
| PubMedID- 25281044 | While hypoglycemia can lead to organ dysfunction, hyperglycemia can lead to surgical site infections (ssi). |
| PubMedID- 24679123 | The continuous need for antidiabetic drugs in dm treatment and chronic hyperglycemia lead to infections, ketoacidosis, hypoglycemia, and micro- and macrovascular disorders affecting the retina and nervous, renal, cardiovascular, and cerebrovascular systems[13]. |
| PubMedID- PMC3363597 | Since hypoglycemia can lead to organ dysfunction, hyperglycemia seems to boost surgical site infections (ssi) [1]. |
| PubMedID- 26177629 | They tested the pharmacodynamics of these constructs in fasted dogs and demonstrated that they could prevent hypoglycemia without inducing temporary hyperglycemia, an event often associated with glucagon alone. |
| PubMedID- 24594704 | Our studies showed that hypoglycemia following hyperglycemia in ferrets produces increases in glucagon and pancreatic polypeptide, similar to that observed in human studies [41]. |
| PubMedID- 22374642 | Given the alterations in the time-action profiles observed in our study, we speculate that postdinner hyperglycemia and increased risk of nocturnal hypoglycemia in the study by nguyen et al. |
| PubMedID- 23594397 | Whereas hyperglycemia was the target of the interventional trials, hypoglycemia was their unifying complication. |
Page: 1